nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—GRIK2—Parkinson's disease	0.338	0.44	CbGaD
Hexobarbital—CHRNA4—Parkinson's disease	0.289	0.377	CbGaD
Hexobarbital—CYP2E1—Parkinson's disease	0.14	0.183	CbGaD
Hexobarbital—CHRNA4—superior cervical ganglion—Parkinson's disease	0.00884	0.0929	CbGeAlD
Hexobarbital—CHRNA4—adrenal medulla—Parkinson's disease	0.00725	0.0762	CbGeAlD
Hexobarbital—GRIK2—cerebellar cortex—Parkinson's disease	0.00619	0.065	CbGeAlD
Hexobarbital—GRIK2—telencephalic ventricle—Parkinson's disease	0.0036	0.0378	CbGeAlD
Hexobarbital—CHRNA4—autonomic nervous system—Parkinson's disease	0.00324	0.0341	CbGeAlD
Hexobarbital—CHRNA4—telencephalic ventricle—Parkinson's disease	0.00289	0.0304	CbGeAlD
Hexobarbital—CHRNA4—peripheral nervous system—Parkinson's disease	0.00234	0.0246	CbGeAlD
Hexobarbital—GRIK2—nerve—Parkinson's disease	0.00227	0.0238	CbGeAlD
Hexobarbital—GRIA2—hindbrain—Parkinson's disease	0.00188	0.0198	CbGeAlD
Hexobarbital—CHRNA4—nerve—Parkinson's disease	0.00182	0.0192	CbGeAlD
Hexobarbital—GABRA6—hindbrain—Parkinson's disease	0.00182	0.0191	CbGeAlD
Hexobarbital—Heptabarbital—GRIK2—Parkinson's disease	0.00172	0.307	CrCbGaD
Hexobarbital—GRIK2—hindbrain—Parkinson's disease	0.0017	0.0179	CbGeAlD
Hexobarbital—Heptabarbital—CHRNA4—Parkinson's disease	0.00147	0.263	CrCbGaD
Hexobarbital—CHRNA4—hindbrain—Parkinson's disease	0.00137	0.0144	CbGeAlD
Hexobarbital—Methylphenobarbital—GRIK2—Parkinson's disease	0.00129	0.232	CrCbGaD
Hexobarbital—GABRA2—hindbrain—Parkinson's disease	0.00122	0.0128	CbGeAlD
Hexobarbital—GABRA1—hindbrain—Parkinson's disease	0.00118	0.0124	CbGeAlD
Hexobarbital—GRIA2—embryo—Parkinson's disease	0.00118	0.0124	CbGeAlD
Hexobarbital—Methylphenobarbital—CHRNA4—Parkinson's disease	0.00111	0.198	CrCbGaD
Hexobarbital—GRIA2—brainstem—Parkinson's disease	0.00108	0.0113	CbGeAlD
Hexobarbital—GABRA6—brainstem—Parkinson's disease	0.00104	0.0109	CbGeAlD
Hexobarbital—GRIA2—forebrain—Parkinson's disease	0.00104	0.0109	CbGeAlD
Hexobarbital—GABRA5—forebrain—Parkinson's disease	0.000975	0.0103	CbGeAlD
Hexobarbital—GRIK2—brainstem—Parkinson's disease	0.000974	0.0102	CbGeAlD
Hexobarbital—CHRFAM7A—forebrain—Parkinson's disease	0.000948	0.00997	CbGeAlD
Hexobarbital—GRIK2—forebrain—Parkinson's disease	0.00094	0.00988	CbGeAlD
Hexobarbital—GABRA4—forebrain—Parkinson's disease	0.000885	0.0093	CbGeAlD
Hexobarbital—CHRNA4—brainstem—Parkinson's disease	0.000783	0.00823	CbGeAlD
Hexobarbital—CHRNA7—forebrain—Parkinson's disease	0.000766	0.00805	CbGeAlD
Hexobarbital—CHRNA4—forebrain—Parkinson's disease	0.000755	0.00794	CbGeAlD
Hexobarbital—GABRA2—brainstem—Parkinson's disease	0.000701	0.00736	CbGeAlD
Hexobarbital—GRIA2—midbrain—Parkinson's disease	0.000687	0.00722	CbGeAlD
Hexobarbital—GRIK2—medulla oblongata—Parkinson's disease	0.000679	0.00714	CbGeAlD
Hexobarbital—GABRA1—brainstem—Parkinson's disease	0.000677	0.00712	CbGeAlD
Hexobarbital—GABRA2—forebrain—Parkinson's disease	0.000676	0.00711	CbGeAlD
Hexobarbital—GRIA2—spinal cord—Parkinson's disease	0.00067	0.00705	CbGeAlD
Hexobarbital—GABRA1—forebrain—Parkinson's disease	0.000654	0.00687	CbGeAlD
Hexobarbital—CHRNA7—cardiovascular system—Parkinson's disease	0.000648	0.00681	CbGeAlD
Hexobarbital—CHRNA4—cardiovascular system—Parkinson's disease	0.000639	0.00671	CbGeAlD
Hexobarbital—GRIK2—midbrain—Parkinson's disease	0.000621	0.00652	CbGeAlD
Hexobarbital—GRIK2—spinal cord—Parkinson's disease	0.000606	0.00637	CbGeAlD
Hexobarbital—GRIA2—head—Parkinson's disease	0.000596	0.00626	CbGeAlD
Hexobarbital—GABRA6—head—Parkinson's disease	0.000576	0.00605	CbGeAlD
Hexobarbital—GRIA2—nervous system—Parkinson's disease	0.000565	0.00594	CbGeAlD
Hexobarbital—GABRA5—head—Parkinson's disease	0.000558	0.00587	CbGeAlD
Hexobarbital—GABRA6—nervous system—Parkinson's disease	0.000546	0.00574	CbGeAlD
Hexobarbital—GRIA2—central nervous system—Parkinson's disease	0.000544	0.00572	CbGeAlD
Hexobarbital—CHRFAM7A—head—Parkinson's disease	0.000543	0.00571	CbGeAlD
Hexobarbital—GRIK2—head—Parkinson's disease	0.000538	0.00566	CbGeAlD
Hexobarbital—GRIA2—cerebellum—Parkinson's disease	0.000532	0.00559	CbGeAlD
Hexobarbital—GABRA5—nervous system—Parkinson's disease	0.000529	0.00556	CbGeAlD
Hexobarbital—GABRA6—central nervous system—Parkinson's disease	0.000525	0.00552	CbGeAlD
Hexobarbital—GABRA3—head—Parkinson's disease	0.00052	0.00546	CbGeAlD
Hexobarbital—CHRFAM7A—nervous system—Parkinson's disease	0.000515	0.00541	CbGeAlD
Hexobarbital—GABRA6—cerebellum—Parkinson's disease	0.000514	0.0054	CbGeAlD
Hexobarbital—GRIK2—nervous system—Parkinson's disease	0.00051	0.00536	CbGeAlD
Hexobarbital—GABRA5—central nervous system—Parkinson's disease	0.00051	0.00536	CbGeAlD
Hexobarbital—GABRA4—head—Parkinson's disease	0.000507	0.00532	CbGeAlD
Hexobarbital—CHRNA4—midbrain—Parkinson's disease	0.000499	0.00524	CbGeAlD
Hexobarbital—CHRFAM7A—central nervous system—Parkinson's disease	0.000496	0.00521	CbGeAlD
Hexobarbital—GABRA3—nervous system—Parkinson's disease	0.000493	0.00518	CbGeAlD
Hexobarbital—GRIK2—central nervous system—Parkinson's disease	0.000491	0.00516	CbGeAlD
Hexobarbital—CHRNA4—spinal cord—Parkinson's disease	0.000487	0.00512	CbGeAlD
Hexobarbital—GABRA4—nervous system—Parkinson's disease	0.00048	0.00505	CbGeAlD
Hexobarbital—GRIK2—cerebellum—Parkinson's disease	0.00048	0.00505	CbGeAlD
Hexobarbital—GABRA3—central nervous system—Parkinson's disease	0.000475	0.00499	CbGeAlD
Hexobarbital—GABRA1—medulla oblongata—Parkinson's disease	0.000472	0.00496	CbGeAlD
Hexobarbital—GABRA4—central nervous system—Parkinson's disease	0.000462	0.00486	CbGeAlD
Hexobarbital—GABRA4—cerebellum—Parkinson's disease	0.000452	0.00475	CbGeAlD
Hexobarbital—CHRNA7—head—Parkinson's disease	0.000438	0.00461	CbGeAlD
Hexobarbital—CHRNA4—head—Parkinson's disease	0.000433	0.00455	CbGeAlD
Hexobarbital—GRIA2—brain—Parkinson's disease	0.000432	0.00454	CbGeAlD
Hexobarbital—GABRA1—midbrain—Parkinson's disease	0.000432	0.00454	CbGeAlD
Hexobarbital—GABRA1—spinal cord—Parkinson's disease	0.000421	0.00443	CbGeAlD
Hexobarbital—GABRA6—brain—Parkinson's disease	0.000417	0.00438	CbGeAlD
Hexobarbital—CHRNA7—nervous system—Parkinson's disease	0.000416	0.00437	CbGeAlD
Hexobarbital—CHRNA4—nervous system—Parkinson's disease	0.00041	0.00431	CbGeAlD
Hexobarbital—GABRA5—brain—Parkinson's disease	0.000405	0.00425	CbGeAlD
Hexobarbital—CHRNA7—central nervous system—Parkinson's disease	0.0004	0.00421	CbGeAlD
Hexobarbital—CHRNA4—central nervous system—Parkinson's disease	0.000395	0.00415	CbGeAlD
Hexobarbital—CHRFAM7A—brain—Parkinson's disease	0.000393	0.00414	CbGeAlD
Hexobarbital—GRIK2—brain—Parkinson's disease	0.00039	0.0041	CbGeAlD
Hexobarbital—GABRA2—head—Parkinson's disease	0.000387	0.00407	CbGeAlD
Hexobarbital—CHRNA4—cerebellum—Parkinson's disease	0.000386	0.00406	CbGeAlD
Hexobarbital—GABRA3—brain—Parkinson's disease	0.000377	0.00396	CbGeAlD
Hexobarbital—GABRA1—head—Parkinson's disease	0.000374	0.00393	CbGeAlD
Hexobarbital—GABRA4—brain—Parkinson's disease	0.000367	0.00386	CbGeAlD
Hexobarbital—GABRA2—nervous system—Parkinson's disease	0.000367	0.00386	CbGeAlD
Hexobarbital—GABRA1—nervous system—Parkinson's disease	0.000355	0.00373	CbGeAlD
Hexobarbital—GABRA2—central nervous system—Parkinson's disease	0.000353	0.00371	CbGeAlD
Hexobarbital—PTGS1—forebrain—Parkinson's disease	0.000348	0.00366	CbGeAlD
Hexobarbital—GABRA2—cerebellum—Parkinson's disease	0.000345	0.00363	CbGeAlD
Hexobarbital—GABRA1—central nervous system—Parkinson's disease	0.000342	0.00359	CbGeAlD
Hexobarbital—GABRA1—cerebellum—Parkinson's disease	0.000334	0.00351	CbGeAlD
Hexobarbital—CYP2C9—cardiovascular system—Parkinson's disease	0.000323	0.00339	CbGeAlD
Hexobarbital—CHRNA7—brain—Parkinson's disease	0.000318	0.00334	CbGeAlD
Hexobarbital—CHRNA4—brain—Parkinson's disease	0.000313	0.00329	CbGeAlD
Hexobarbital—CYP2E1—cardiovascular system—Parkinson's disease	0.000306	0.00321	CbGeAlD
Hexobarbital—PTGS1—cardiovascular system—Parkinson's disease	0.000295	0.0031	CbGeAlD
Hexobarbital—GABRA2—brain—Parkinson's disease	0.000281	0.00295	CbGeAlD
Hexobarbital—GABRA1—brain—Parkinson's disease	0.000271	0.00285	CbGeAlD
Hexobarbital—CYP2E1—medulla oblongata—Parkinson's disease	0.000261	0.00275	CbGeAlD
Hexobarbital—CYP2E1—spinal cord—Parkinson's disease	0.000233	0.00245	CbGeAlD
Hexobarbital—PTGS1—spinal cord—Parkinson's disease	0.000224	0.00236	CbGeAlD
Hexobarbital—CYP2E1—head—Parkinson's disease	0.000207	0.00218	CbGeAlD
Hexobarbital—PTGS1—head—Parkinson's disease	0.000199	0.0021	CbGeAlD
Hexobarbital—CYP2E1—nervous system—Parkinson's disease	0.000196	0.00206	CbGeAlD
Hexobarbital—PTGS1—nervous system—Parkinson's disease	0.000189	0.00199	CbGeAlD
Hexobarbital—CYP2E1—central nervous system—Parkinson's disease	0.000189	0.00199	CbGeAlD
Hexobarbital—CYP2E1—cerebellum—Parkinson's disease	0.000185	0.00194	CbGeAlD
Hexobarbital—PTGS1—central nervous system—Parkinson's disease	0.000182	0.00191	CbGeAlD
Hexobarbital—CYP3A4—nervous system—Parkinson's disease	0.000158	0.00166	CbGeAlD
Hexobarbital—CYP3A4—central nervous system—Parkinson's disease	0.000152	0.0016	CbGeAlD
Hexobarbital—CYP2E1—brain—Parkinson's disease	0.00015	0.00158	CbGeAlD
Hexobarbital—PTGS1—brain—Parkinson's disease	0.000145	0.00152	CbGeAlD
Hexobarbital—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	3.45e-05	0.000263	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.41e-05	0.00026	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.4e-05	0.000259	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.38e-05	0.000258	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.38e-05	0.000258	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.37e-05	0.000257	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—NDUFB11—Parkinson's disease	3.36e-05	0.000256	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—COMT—Parkinson's disease	3.35e-05	0.000256	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.34e-05	0.000255	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	3.34e-05	0.000255	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	3.33e-05	0.000254	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	3.31e-05	0.000252	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	3.29e-05	0.000251	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.29e-05	0.000251	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.27e-05	0.000249	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.24e-05	0.000247	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.21e-05	0.000245	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GCH1—Parkinson's disease	3.21e-05	0.000245	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.2e-05	0.000244	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.2e-05	0.000244	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.16e-05	0.000241	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	3.15e-05	0.00024	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.11e-05	0.000237	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.11e-05	0.000237	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.07e-05	0.000234	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	3.07e-05	0.000234	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—COMT—Parkinson's disease	3.06e-05	0.000233	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	3.04e-05	0.000232	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	3.04e-05	0.000232	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	3.02e-05	0.000231	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	3.02e-05	0.00023	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	3e-05	0.000229	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.89e-05	0.000221	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	2.88e-05	0.00022	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GBA—Parkinson's disease	2.86e-05	0.000218	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—DBH—Parkinson's disease	2.86e-05	0.000218	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—FBP1—Parkinson's disease	2.86e-05	0.000218	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.84e-05	0.000217	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ND3—Parkinson's disease	2.82e-05	0.000215	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MCCC1—Parkinson's disease	2.82e-05	0.000215	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.8e-05	0.000214	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	2.8e-05	0.000213	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	2.79e-05	0.000213	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.79e-05	0.000213	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	2.76e-05	0.00021	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.74e-05	0.000209	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.73e-05	0.000208	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.69e-05	0.000205	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.68e-05	0.000204	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.66e-05	0.000203	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TALDO1—Parkinson's disease	2.65e-05	0.000202	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—OMD—Parkinson's disease	2.65e-05	0.000202	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.63e-05	0.000201	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.62e-05	0.0002	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—COMT—Parkinson's disease	2.61e-05	0.000199	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	2.61e-05	0.000199	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	2.61e-05	0.000199	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	2.6e-05	0.000198	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	2.59e-05	0.000198	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	2.58e-05	0.000197	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	2.56e-05	0.000196	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	2.51e-05	0.000192	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.46e-05	0.000187	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	2.43e-05	0.000186	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.4e-05	0.000183	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GCH1—Parkinson's disease	2.4e-05	0.000183	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	2.39e-05	0.000182	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	2.36e-05	0.00018	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.34e-05	0.000178	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.31e-05	0.000176	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.24e-05	0.000171	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ND3—Parkinson's disease	2.17e-05	0.000166	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MCCC1—Parkinson's disease	2.17e-05	0.000166	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GBA—Parkinson's disease	2.14e-05	0.000163	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—FBP1—Parkinson's disease	2.14e-05	0.000163	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—DBH—Parkinson's disease	2.14e-05	0.000163	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.11e-05	0.000161	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—DDC—Parkinson's disease	2.1e-05	0.00016	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TALDO1—Parkinson's disease	2.04e-05	0.000156	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—OMD—Parkinson's disease	2.04e-05	0.000156	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.02e-05	0.000154	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.01e-05	0.000153	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2e-05	0.000153	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	1.99e-05	0.000152	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MCCC1—Parkinson's disease	1.98e-05	0.000151	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ND3—Parkinson's disease	1.98e-05	0.000151	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.98e-05	0.000151	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTA4—Parkinson's disease	1.98e-05	0.000151	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	1.98e-05	0.000151	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.96e-05	0.000149	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	1.94e-05	0.000148	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TALDO1—Parkinson's disease	1.86e-05	0.000142	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—OMD—Parkinson's disease	1.86e-05	0.000142	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GCH1—Parkinson's disease	1.85e-05	0.000141	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.84e-05	0.000141	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.82e-05	0.000139	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.8e-05	0.000137	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—PLA2G6—Parkinson's disease	1.78e-05	0.000136	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	1.77e-05	0.000135	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MAOB—Parkinson's disease	1.77e-05	0.000135	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ND3—Parkinson's disease	1.69e-05	0.000129	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MCCC1—Parkinson's disease	1.69e-05	0.000129	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GCH1—Parkinson's disease	1.69e-05	0.000129	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.68e-05	0.000128	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.67e-05	0.000127	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—DBH—Parkinson's disease	1.65e-05	0.000126	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—FBP1—Parkinson's disease	1.65e-05	0.000126	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GBA—Parkinson's disease	1.65e-05	0.000126	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TALDO1—Parkinson's disease	1.59e-05	0.000121	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—OMD—Parkinson's disease	1.59e-05	0.000121	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—DDC—Parkinson's disease	1.57e-05	0.00012	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.52e-05	0.000116	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	1.51e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—DBH—Parkinson's disease	1.5e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GBA—Parkinson's disease	1.5e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.5e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.48e-05	0.000113	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.44e-05	0.00011	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.33e-05	0.000102	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.32e-05	0.000101	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYP2D6—Parkinson's disease	1.31e-05	0.0001	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ND3—Parkinson's disease	1.31e-05	9.97e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.31e-05	9.97e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.3e-05	9.91e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CTGF—Parkinson's disease	1.29e-05	9.83e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.28e-05	9.79e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—DBH—Parkinson's disease	1.28e-05	9.79e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GBA—Parkinson's disease	1.28e-05	9.79e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.23e-05	9.38e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—OMD—Parkinson's disease	1.23e-05	9.38e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—DDC—Parkinson's disease	1.21e-05	9.23e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYP2E1—Parkinson's disease	1.2e-05	9.16e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—NQO1—Parkinson's disease	1.19e-05	9.05e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—TH—Parkinson's disease	1.17e-05	8.92e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.17e-05	8.89e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.14e-05	8.71e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.13e-05	8.6e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYCS—Parkinson's disease	1.12e-05	8.57e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.11e-05	8.48e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—DDC—Parkinson's disease	1.1e-05	8.41e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.04e-05	7.94e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.03e-05	7.84e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.03e-05	7.84e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.02e-05	7.77e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—COMT—Parkinson's disease	9.95e-06	7.59e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—FBP1—Parkinson's disease	9.91e-06	7.56e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—DBH—Parkinson's disease	9.91e-06	7.56e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GBA—Parkinson's disease	9.91e-06	7.56e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTP1—Parkinson's disease	9.9e-06	7.55e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MAOA—Parkinson's disease	9.88e-06	7.53e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	9.81e-06	7.48e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—HMOX1—Parkinson's disease	9.76e-06	7.45e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.69e-06	7.39e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CTGF—Parkinson's disease	9.63e-06	7.34e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—DDC—Parkinson's disease	9.43e-06	7.19e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	9.38e-06	7.15e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ABCB1—Parkinson's disease	9.37e-06	7.15e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MAOB—Parkinson's disease	9.28e-06	7.08e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTM1—Parkinson's disease	9.1e-06	6.94e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTA4—Parkinson's disease	8.9e-06	6.79e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NQO1—Parkinson's disease	8.87e-06	6.76e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.84e-06	6.74e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	8.79e-06	6.7e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TH—Parkinson's disease	8.74e-06	6.67e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GPX1—Parkinson's disease	8.71e-06	6.64e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYCS—Parkinson's disease	8.39e-06	6.4e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MTHFR—Parkinson's disease	8.04e-06	6.13e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	8.01e-06	6.11e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MAOB—Parkinson's disease	7.93e-06	6.05e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	7.57e-06	5.77e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.55e-06	5.76e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—APOE—Parkinson's disease	7.49e-06	5.71e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—COMT—Parkinson's disease	7.43e-06	5.67e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CTGF—Parkinson's disease	7.43e-06	5.66e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTP1—Parkinson's disease	7.4e-06	5.64e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MAOA—Parkinson's disease	7.38e-06	5.63e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—HMOX1—Parkinson's disease	7.3e-06	5.56e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—DDC—Parkinson's disease	7.27e-06	5.55e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ABCB1—Parkinson's disease	7e-06	5.34e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	6.92e-06	5.28e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	6.9e-06	5.26e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.87e-06	5.24e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NQO1—Parkinson's disease	6.84e-06	5.22e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTM1—Parkinson's disease	6.8e-06	5.18e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CTGF—Parkinson's disease	6.77e-06	5.17e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TH—Parkinson's disease	6.74e-06	5.14e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GPX1—Parkinson's disease	6.51e-06	4.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYCS—Parkinson's disease	6.48e-06	4.94e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—INS—Parkinson's disease	6.39e-06	4.88e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	6.31e-06	4.81e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NQO1—Parkinson's disease	6.24e-06	4.76e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.19e-06	4.72e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TH—Parkinson's disease	6.15e-06	4.69e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.12e-06	4.67e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MTHFR—Parkinson's disease	6.01e-06	4.58e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYCS—Parkinson's disease	5.9e-06	4.5e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	5.9e-06	4.5e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CTGF—Parkinson's disease	5.79e-06	4.41e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—COMT—Parkinson's disease	5.73e-06	4.37e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTP1—Parkinson's disease	5.71e-06	4.35e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MAOA—Parkinson's disease	5.69e-06	4.34e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—HMOX1—Parkinson's disease	5.63e-06	4.29e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—APOE—Parkinson's disease	5.59e-06	4.27e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ABCB1—Parkinson's disease	5.4e-06	4.12e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.39e-06	4.11e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NQO1—Parkinson's disease	5.33e-06	4.07e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TH—Parkinson's disease	5.26e-06	4.01e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTM1—Parkinson's disease	5.25e-06	4e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—COMT—Parkinson's disease	5.23e-06	3.99e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTP1—Parkinson's disease	5.2e-06	3.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MAOA—Parkinson's disease	5.19e-06	3.96e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—HMOX1—Parkinson's disease	5.13e-06	3.91e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYCS—Parkinson's disease	5.05e-06	3.85e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GPX1—Parkinson's disease	5.02e-06	3.83e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ABCB1—Parkinson's disease	4.93e-06	3.76e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTM1—Parkinson's disease	4.78e-06	3.65e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—INS—Parkinson's disease	4.78e-06	3.64e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MTHFR—Parkinson's disease	4.64e-06	3.54e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.58e-06	3.49e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.55e-06	3.47e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—COMT—Parkinson's disease	4.47e-06	3.41e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.47e-06	3.41e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.45e-06	3.39e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.44e-06	3.38e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.39e-06	3.35e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—APOE—Parkinson's disease	4.32e-06	3.29e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.23e-06	3.22e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ABCB1—Parkinson's disease	4.21e-06	3.21e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.16e-06	3.17e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.12e-06	3.14e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.09e-06	3.12e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TH—Parkinson's disease	4.06e-06	3.09e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—APOE—Parkinson's disease	3.93e-06	3e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.91e-06	2.98e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.89e-06	2.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—INS—Parkinson's disease	3.69e-06	2.81e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.61e-06	2.75e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—COMT—Parkinson's disease	3.45e-06	2.63e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.43e-06	2.62e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.42e-06	2.61e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.39e-06	2.58e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—APOE—Parkinson's disease	3.36e-06	2.56e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—INS—Parkinson's disease	3.36e-06	2.56e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.25e-06	2.48e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.15e-06	2.41e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.02e-06	2.3e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—INS—Parkinson's disease	2.87e-06	2.19e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.79e-06	2.13e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—APOE—Parkinson's disease	2.6e-06	1.98e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—INS—Parkinson's disease	2.22e-06	1.69e-05	CbGpPWpGaD
